Idex stock

IEX · NYSE · USD

Compare Idex
$219.64Change from previous close: −3.25%Absolute change: −$7.37

Close · November 20, 2026

Price history

+34.75% over the period

1 year: from $163.00 (November 20, 2025) to $219.64 (November 20, 2026), +34.75%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$219.64
October 30, 2026$233.84
September 30, 2026$227.98
August 31, 2026$228.64
July 31, 2026$230.45
June 30, 2026$226.95
May 29, 2026$210.83
April 30, 2026$217.85
March 31, 2026$189.55
February 27, 2026$209.47
January 30, 2026$198.55
December 31, 2025$177.94
November 28, 2025$173.93
November 20, 2025$163.00

At a glance

  • The company

    Manufactures precision fluidics, pumps, sealing solutions, medical devices, flow control equipment and firefighting systems across health, fluid handling and safety applications

  • Latest results

    Quarter to September 30, 2026 · EPS $2.33 (estimate $2.24)

TickerLandia's take on Idex

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$168.92
52-wk high$243.80

−9.91% from the 52-week high

Analysts · 15 analysts

Average target$262.93+19.71% vs. price

Buy 10 · Hold 5 · Sell 0 · Buy

TickerLandia Fingerprint: Idex

Compared with similar companies: low risk, high profitability, and strong momentum.

Financials and price compared with 94 companies in the specialty industrial machinery industry, worldwide. Momentum and risk compared with 888 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Idex is priced as in the past and in line with similar companies

On the latest fiscal year's earnings (2025), Idex's P/E today is 34.3, in line with the median of its last 10 fiscal years (29.9; between 23.9 and 40.3 from 2016 to 2025). Idex's P/E (trailing 12 months): 30.5, in line with the median of a group of 11 similar companies (31.1).

P/E compared with its history

Compared with 11 similar companies

Idex's metrics compared with similar companies
MetricIdexPosition in the groupBand
P/E (trailing 12 months)30.5Middle
Forward P/E22.3Middle
Operating margin21.4%High
ROE13.3%Middle
Debt/equity0.44Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Idex. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$951.7M

Latest quarter · Q3 2026

Net income

$144.1M

Latest quarter · Q3 2026

Quarterly net margin

15.1%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$16.13B
P/E
30.5
EPS
$7.20
Volume
760.18K
Daily trading
€168.84M
Dividend yield
1.32%

How Idex is changing

All results
  • Revenue grew 8.0% a year on average over the last 5 years

  • Operating margin fell from 23.6% to 20.2%

  • Profits turn into cash: free cash flow equal to 117% of net income

Returns

Idex returns with dividends

$1,000 invested in Idex 5 years ago, on November 22, 2021, would be worth $996 today with dividends reinvested: −0.39% in total, −0.08% per year. On price alone it would be $933 (−6.66%).

PeriodIdexS&P 500$1,000 becomes
1 month−5.80%−10.40%$942
6 months+5.50%−7.03%$1,055
Year to date+23.43%+0.95%$1,234
1 year+36.58%+5.68%$1,366
3 years+16.97%+51.96%$1,170
5 years−0.39%+47.57%$996
10 years+168.97%+214.37%$2,690

Over the last 6 months it has done better than 77% of the stocks in the Industrials sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Idex: technical analysis

Idex shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 10.7% below its highest close since January 2, 1990 ($245.87, March 21, 2024).

Trend
No clear trend
RSI (14 sessions)
36
Between 30 and 70
vs 200-session average
+0.41%

Active signals

  • Close below the low of the previous 20 sessions.

Support and resistance

Price areas where Idex has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$241.64+10.02%6 touches, last on November 11, 2026
  2. Resistance$230.94+5.14%2 touches, last on July 17, 2026
  3. Resistance$223.47+1.74%4 touches, last on November 5, 2026
  4. Last price$219.64
  5. Support$217.64−0.91%4 touches, last on September 16, 2026
  6. Support$211.44−3.73%3 touches, last on June 11, 2026
  7. Support$203.10−7.53%4 touches, last on May 20, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.78
Volatility (60 sessions, annualised)
23.8%
Largest fall in the last year
−14.49%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Idex: seasonality

Average monthly price change over 37 years

+0.3%Jan+1.1%Feb+1.6%Mar+4.6%Apr+1.5%May+1.4%Jun+0.9%Jul−1.7%Aug−1.1%Sep+1.7%Oct+4.6%Nov+1.5%Dec

Over the last 37 years, the strongest month for Idex has been November: +4.59% on average, positive in 32 years out of 36. The weakest has been August: −1.69% on average, positive in 14 years out of 37.

Show chart data
MonthAverageMedianPositive years
January+0.28%−1.97%16 of 36
February+1.12%+2.46%26 of 37
March+1.62%+2.15%23 of 37
April+4.58%+3.24%26 of 37
May+1.46%+2.22%25 of 37
June+1.38%+0.33%20 of 37
July+0.93%+1.54%20 of 37
August−1.69%−0.79%14 of 37
September−1.10%−0.74%14 of 37
October+1.67%+2.57%26 of 37
November+4.59%+4.53%32 of 36
December+1.51%+2.41%24 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Idex and its competitors

Sales of IDEX Corporation are spread across the United States, which accounts for 50.9% of revenue, Europe with 24.5%, Asia with 16.3%, North America excluding the United States with 3.8% and other areas with 4.8%. Operating through subsidiaries, the company runs three segments. Health & Science Technologies covers precision fluidics, positive displacement pumps, drying systems, sealing components, medical devices, optical components and photonic solutions.

Headquarters
Northbrook, United States
Employees
8,700
Founded
1987
Chief executive
Eric Ashleman
Idex and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
IdexIEX$16.13B21.4%30.5+5.50%
NordsonNDSN$17.12B27.2%31.1+11.23%
ITTITT$17.94B15.9%41.4+4.01%
SymboticSYM$18.83B0.5%388.8−37.75%
XylemXYL$21.71B15.5%21.0−12.53%
Crane CompanyCR$11.69B17.7%34.7+16.56%

Same industry or related industries, similar size. Compare Idex with its competitors · Full profile